Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.

Authors:
Address: Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Journal:


Publication:

abstract

Nuclear transcription factor Nrf2 regulates the expression and coordinated induction of a battery of genes encoding cytoprotective and drug transporter proteins in response to chemical and radiation stress. This leads to reduced apoptosis, enhanced cell survival, and increased drug resistance. In this study, we investigated the role of Nrf2 in up-regulation of antiapoptotic protein Bcl-2 and its contribution to stress-induced apoptosis and cell survival. Exposure of mouse hepatoma (Hepa-1) and human hepatoblastoma (HepG2) cells to antioxidant tert-butylhydroquinone led to induction of Bcl-2. Mutagenesis and transfection assays identified an antioxidant response element between nucleotides -3148 and -3140 on the reverse strand of the Bcl-2 gene promoter that was essential for activation of Bcl-2 gene expression. Band/supershift and ChIP assays demonstrated binding of Nrf2 to Bcl-2 antioxidant response element. Alterations in Nrf2 led to altered Bcl-2 induction and cellular apoptosis. Moreover, dysfunctional/mutant inhibitor of Nrf2 (INrf2) in human lung cancer cells failed to degrade Nrf2, resulting in an increased Bcl-2 level and decreased etoposide- and UV/γ radiation-mediated DNA fragmentation. In addition, siRNA-mediated down-regulation of Nrf2 also led to decreased apoptosis and increased cell survival. Furthermore, the specific knockdown of Bcl-2 in Nrf2-activated tumor cells led to increased etoposide-induced apoptosis and decreased cell survival and growth/proliferation. These data provide the first evidence of Nrf2 in control of Bcl-2 expression and apoptotic cell death with implications in antioxidant protection, survival of cancer cells, and drug resistance.



Related Articles
INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
Cell Death Differ. 2011
INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
Niture SK, Jaiswal AK. Cell Death Differ. 2011 Mar; 18(3):439-51. Epub 2010 Sep 24.
Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression.
J Biol Chem. 2011
Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression.
Niture SK, Jain AK, Shelton PM, Jaiswal AK. J Biol Chem. 2011 Aug 19; 286(33):28821-32. Epub 2011 Jun 20.
Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.
J Cell Sci. 2009
Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.
Niture SK, Jain AK, Jaiswal AK. J Cell Sci. 2009 Dec 15; 122(Pt 24):4452-64. Epub 2009 Nov 17.
An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance.
J Biol Chem. 2007
An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance.
Lee OH, Jain AK, Papusha V, Jaiswal AK. J Biol Chem. 2007 Dec 14; 282(50):36412-20. Epub 2007 Oct 9.
Review Nrf2 signaling and cell survival.
Toxicol Appl Pharmacol. 2010
Review Nrf2 signaling and cell survival.
Niture SK, Kaspar JW, Shen J, Jaiswal AK. Toxicol Appl Pharmacol. 2010 Apr 1; 244(1):37-42. Epub 2009 Jun 16.
Mitochondria: redox metabolism and dysfunction.
Biochem Res Int. 2012
Mitochondria: redox metabolism and dysfunction.
Kang J, Pervaiz S. Biochem Res Int. 2012; 2012:896751. Epub 2012 Apr 24.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.